INVALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Patients with SOF/VEL treatment for the treatment │ Patients with SOF/VEL treatment for the treatment │     100 │
│ of chronic HCV genotype 1 through 6               │ of chronic HCV genotype 1 through 6               │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patient is at least 18 at the day of screening    │ Patient is at least 18 at the day of screening    │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patient is able and willing to sign the Informed  │ Patient is able and willing to sign the Informed  │     100 │
│ Consent Form                                      │ Consent Form                                      │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patient is able and willing to follow protocol    │ Patient is able and willing to follow protocol    │     100 │
│ requirements                                      │ requirements                                      │         │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒════════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                     │   Score │
╞════════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years                  │ Patient is at least 18 at the day of screening    │      35 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Relevant history or current condition that might   │ Patient is able and willing to sign the Informed  │      39 │
│ interfere with drug absorption, distribution,      │ Consent Form                                      │         │
│ metabolism or excretion                            │                                                   │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Clinically relevant low hemoglobin concentration   │ Patients with SOF/VEL treatment for the treatment │      40 │
│ at screening judged by the patient's own           │ of chronic HCV genotype 1 through 6               │         │
│ hepatologist                                       │                                                   │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Inability to understand the nature and extent of   │ Patients with SOF/VEL treatment for the treatment │      44 │
│ the study and the procedures required              │ of chronic HCV genotype 1 through 6               │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Pregnant female (as confirmed by an hCG urine test │ Patient is able and willing to sign the Informed  │      45 │
│ performed at screening) or breast-feeding female   │ Consent Form                                      │         │
╘════════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒═══════════════════════════════════════════════════╤═════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria   │   Score │
╞═══════════════════════════════════════════════════╪═════════════════╪═════════╡
│ Patients with SOF/VEL treatment for the treatment │ NA              │       0 │
│ of chronic HCV genotype 1 through 6               │                 │         │
╘═══════════════════════════════════════════════════╧═════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 53
Average Levenshtein Ratio of individual lines: 60.3
OverAll Ratio: 56.65
